NCT02250885View on ClinicalTrials.gov

KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Carcinoma, Neuroendocrine
Interventions
DRUG

Selinexor

Selective Inhibitor fo Nuclear Export (SINE)

Trial Locations (1)

44718

Gabrail Cancer Center Research, Canton

Sponsors
All Listed Sponsors
collaborator

Karyopharm Therapeutics Inc

INDUSTRY

lead

Gabrail Cancer Center Research

OTHER